[go: up one dir, main page]

WO2015166419A3 - Proceso de obtención y composición farmacéutica de ketorolaco trometamina y clorhidrato de tramadol sublingual usado para el dolor - Google Patents

Proceso de obtención y composición farmacéutica de ketorolaco trometamina y clorhidrato de tramadol sublingual usado para el dolor Download PDF

Info

Publication number
WO2015166419A3
WO2015166419A3 PCT/IB2015/053098 IB2015053098W WO2015166419A3 WO 2015166419 A3 WO2015166419 A3 WO 2015166419A3 IB 2015053098 W IB2015053098 W IB 2015053098W WO 2015166419 A3 WO2015166419 A3 WO 2015166419A3
Authority
WO
WIPO (PCT)
Prior art keywords
pain
pharmaceutical composition
tramadol hydrochloride
ketorolac tromethamine
production method
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/IB2015/053098
Other languages
English (en)
French (fr)
Other versions
WO2015166419A2 (es
Inventor
Oliver Daniel WALLS FLORES
Ramón RODRÍGUEZ HERNÁNDEZ
Eduardo BARRENA HERNÁNDEZ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratorios Liomont SA de CV
Original Assignee
Laboratorios Liomont SA de CV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=54359445&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=WO2015166419(A3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Laboratorios Liomont SA de CV filed Critical Laboratorios Liomont SA de CV
Publication of WO2015166419A2 publication Critical patent/WO2015166419A2/es
Publication of WO2015166419A3 publication Critical patent/WO2015166419A3/es
Priority to SV2016005309A priority Critical patent/SV2016005309A/es
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

Una composición farmacéutica oral de la combinación de ketrolaco trometamina / clorhidrato de tramadol para el tratamiento de alopatías relacionadas con el dolor (de moderado a severo), analgésico, antiinflamatorio, fiebre o antipirética, para su administración oral y en específico como una tableta sublingual.
PCT/IB2015/053098 2014-04-29 2015-04-29 Proceso de obtención y composición farmacéutica de ketorolaco trometamina y clorhidrato de tramadol sublingual usado para el dolor Ceased WO2015166419A2 (es)

Priority Applications (1)

Application Number Priority Date Filing Date Title
SV2016005309A SV2016005309A (es) 2014-04-29 2016-10-28 Proceso de obtenciã“n y composiciã“n farmacã‰utica para de ketorolaco trometamina y clorhidrato de tramadol sublingual usado para el dolor

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
MXMX/A/2014/005153 2014-04-29
MX2014005153A MX2014005153A (es) 2014-04-29 2014-04-29 Proceso de obtencion y composicion farmaceutica de ketorolaco trometamina y clorhidrato de tramadol sublingual usado para el dolor.

Publications (2)

Publication Number Publication Date
WO2015166419A2 WO2015166419A2 (es) 2015-11-05
WO2015166419A3 true WO2015166419A3 (es) 2016-01-07

Family

ID=54359445

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2015/053098 Ceased WO2015166419A2 (es) 2014-04-29 2015-04-29 Proceso de obtención y composición farmacéutica de ketorolaco trometamina y clorhidrato de tramadol sublingual usado para el dolor

Country Status (4)

Country Link
CL (1) CL2016002656A1 (es)
MX (1) MX2014005153A (es)
SV (1) SV2016005309A (es)
WO (1) WO2015166419A2 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2607661C1 (ru) * 2015-11-30 2017-01-10 Федеральное государственное бюджетное учреждение науки Институт органического синтеза им. И.Я. Постовского Уральского отделения Российской академии наук (ИОС УрО РАН) Ректальные суппозитории, обладающие болеутоляющим действием
MX2018003456A (es) 2017-12-21 2019-09-06 Gruenenthal Gmbh Combinacion farmaceutica en la forma de comprimidos en bicapa que comprende ketorolaco trometamina y tramadol clorhidrato, y su uso para el tratamiento del dolor.
MX389850B (es) 2018-01-22 2025-03-20 Federico Amezcua Amezcua Composicion farmaceutica sinergica del enantiomero activo s-ketorolaco trometamina y clorhidrato de tramadol.

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008120966A1 (es) * 2007-04-02 2008-10-09 Espinosa Abdala Leopoldo De Jesus Composición farmacéutica en forma de tableta sublingual que comprende un antiinflamatorio no esteroideo y un analgésico opiáceo para el manejo del dolor.

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008120966A1 (es) * 2007-04-02 2008-10-09 Espinosa Abdala Leopoldo De Jesus Composición farmacéutica en forma de tableta sublingual que comprende un antiinflamatorio no esteroideo y un analgésico opiáceo para el manejo del dolor.

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
GAMMADOL: "prospecto, efectos adversos, preguntas frecuentes;", 25 November 2013 (2013-11-25), Retrieved from the Internet <URL:http://www.doctoralia.com.mx/medicamento/gammadol-54051> [retrieved on 20151020] *

Also Published As

Publication number Publication date
WO2015166419A2 (es) 2015-11-05
MX2014005153A (es) 2015-10-28
CL2016002656A1 (es) 2017-02-17
SV2016005309A (es) 2017-05-15

Similar Documents

Publication Publication Date Title
PH12020500066A1 (en) Carboxamides as modulators of sodium channels
PH12018502251A1 (en) Formulations of an lsd1 inhibitor
WO2015077503A8 (en) Autotaxin inhibitor compounds
ZA202105976B (en) Pharmaceutical dosage form for application to mucous membranes and methods for producing same
WO2011104652A3 (en) Veterinary compositions
IN2015DN01023A (es)
MX2017015137A (es) Composicion farmaceutica oral de dosis diaria de isotretinoin.
NZ735777A (en) Methods and compositions to inhibit symptoms associated with veisalgia
EP4342461A3 (en) Pharmaceutical compositions and uses directed to lysosomal storage disorders
WO2015125152A3 (en) Pharmaceutical compositions of asenapine
EP3725297A4 (en) ORAL PHARMACEUTICAL COMPOSITION CONTAINING PEMETREXED AND RELATED PRODUCTION PROCESS
PH12015501377A1 (en) Solid unit with high fexofenadine content and process for the preparation thereof
WO2015166419A3 (es) Proceso de obtención y composición farmacéutica de ketorolaco trometamina y clorhidrato de tramadol sublingual usado para el dolor
WO2016142821A3 (en) Compositions containing a thrombin inhibitor
EP3648745A4 (en) PHARMACEUTICAL COMPOSITION WITH SPHERICAL TABLET OF MULTIPLE UNITS WITH AMEOMEPRAZOLE AND SPHERICAL PHARMACEUTICAL SALT THEREOF AND METHOD FOR MANUFACTURING THE PHARMACEUTICAL COMPOSITION
TR201722603A2 (tr) Metformi̇n ve si̇tagli̇pti̇n i̇çeren sicak eri̇tme ekstrüzyonu i̇le gerçekleşti̇ri̇len tablet formülasyonlari
EA202090913A1 (ru) Композиция таблеток с модифицированным высвобождением, содержащая мирабегрон
MX2017015322A (es) Composicion farmaceutica oral de isotretinoin.
WO2014125504A3 (en) Pharmaceutical compositions of febuxostat
EP3381467A4 (en) PHARMACEUTICAL VACCINE COMPOSITION FOR ORAL ADMINISTRATION AND METHOD FOR PREPARING A PHARMACEUTICAL VACCINE COMPOSITION FOR ORAL ADMINISTRATION
WO2019132729A3 (ru) Фармацевтические композиции на основе ментилового эфира индометацина и его применение
WO2015166418A3 (es) Composición farmacéutica para el tratamiento de alopatías relacionadas con el dolor, usando como agente activo al ketorolaco trometamina y clorhidrato de tramadol
MX2016006464A (es) Composicion farmaceutica de una combinacion de clorhidrato de tramadol-etoricoxib para el tratamiento del dolor.
PH12020500045A1 (en) Novel composition of enzalutamide oral dosage form and method of manufacturing thereof
MX370184B (es) Composición farmacéutica que comprende fingolimod.

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 15786382

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 15786382

Country of ref document: EP

Kind code of ref document: A2